Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
CanSinoBIO receives EU GMP certification for Convidecia
CanSinoBIO's Convidecia COVID-19 vaccine received a Good Manufacturing Practice certificate from Hungary's National Institute of Pharmacy and Nutrition after an inspection of the company's vaccine production.
2020
JD Health and CanSino enter strategic partnership
JD Health and CanSino entered a strategic partnership to jointly develop an online vaccine service platform. The article says a CanSino vaccine was planned to debut on JD Health after approval.
2020
Shanghai Pharmaceuticals and CanSino Biologics sign strategic cooperation agreement
Shanghai Pharmaceuticals and CanSino Biologics signed a strategic cooperation agreement covering vaccine research and development, production and capacity expansion, materials reserves, and supply-chain development. The agreement also provides for nationwide vaccine storage, distribution, and supply-chain services.
2020
Pfizer and CanSino vaccine collaboration
Pfizer and CanSino are collaborating, with Pfizer's vaccine promotion team joining the collaboration.
2019
CanSino proposes an A-share offering and STAR Market listing
CanSino Biologics announced a proposal to apply to relevant Chinese regulators to issue up to 24.8 million A shares and seek approval for their listing and trading on the Shanghai Stock Exchange STAR Market.